Status:
RECRUITING
Comparative Effectiveness of CET vs. SST in SMI (Serious Mental Illness)
Lead Sponsor:
Beth Israel Deaconess Medical Center
Collaborating Sponsors:
Patient-Centered Outcomes Research Institute
Conditions:
Schizophrenia and Related Disorders
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
To compare two evidence-based treatments, Cognitive Enhancement Therapy (CET) and Social Skills Training (SST) that have been shown in meta-analyses and in our own research to be effective to improve ...
Detailed Description
Aim 1. We will test our hypothesis that CET will be associated with greater improvements than SST in both the primary outcome: community functioning (SAS, QLS), and the secondary outcomes of neuro- an...
Eligibility Criteria
Inclusion
- age 18 to 65;
- DSM-5 diagnosis of schizophrenia or schizoaffective or schizophreniform disorder (confirmed via the MINI diagnostic interview);
- estimated IQ of \> 70 (established via WTAR).
Exclusion
- the presence of a current organic brain syndrome;
- intellectual disability (DSM-5);
- participation in either CET or SST within the prior year.
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2026
Estimated Enrollment :
378 Patients enrolled
Trial Details
Trial ID
NCT04321759
Start Date
June 1 2021
End Date
January 31 2026
Last Update
November 14 2023
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Hartford Hospital - Institute of Living
Hartford, Connecticut, United States, 06106
2
Maine Medical Center
Portland, Maine, United States, 04102
3
Massachusetts Mental Health Center
Boston, Massachusetts, United States, 02115
4
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215